PT97108A - Processo para a preparacao de medicamentos contendo antagonistas de bcrf1 uteis para o tratamento de infeccoes pelo virus de epstein-barr - Google Patents

Processo para a preparacao de medicamentos contendo antagonistas de bcrf1 uteis para o tratamento de infeccoes pelo virus de epstein-barr

Info

Publication number
PT97108A
PT97108A PT97108A PT9710891A PT97108A PT 97108 A PT97108 A PT 97108A PT 97108 A PT97108 A PT 97108A PT 9710891 A PT9710891 A PT 9710891A PT 97108 A PT97108 A PT 97108A
Authority
PT
Portugal
Prior art keywords
bcrf1
infections
utah
epstein
antagonists
Prior art date
Application number
PT97108A
Other languages
English (en)
Other versions
PT97108B (pt
Inventor
Kevin W Moore
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PT97108A publication Critical patent/PT97108A/pt
Publication of PT97108B publication Critical patent/PT97108B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97108A 1990-03-26 1991-03-22 Processo para a preparacao de medicamentos contendo antagonistas de bcrf1 uteis para o tratamento de infeccoes pelo virus de epstein-barr PT97108B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49898590A 1990-03-26 1990-03-26

Publications (2)

Publication Number Publication Date
PT97108A true PT97108A (pt) 1991-11-29
PT97108B PT97108B (pt) 1998-10-30

Family

ID=23983319

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97108A PT97108B (pt) 1990-03-26 1991-03-22 Processo para a preparacao de medicamentos contendo antagonistas de bcrf1 uteis para o tratamento de infeccoes pelo virus de epstein-barr

Country Status (23)

Country Link
US (1) US5756342A (pt)
EP (1) EP0522010B1 (pt)
JP (1) JP2509774B2 (pt)
KR (1) KR960004856B1 (pt)
CN (1) CN1056245A (pt)
AT (1) ATE126704T1 (pt)
AU (1) AU650013B2 (pt)
CA (1) CA2079230C (pt)
DE (1) DE69112392T2 (pt)
DK (1) DK0522010T3 (pt)
ES (1) ES2076526T3 (pt)
FI (1) FI924278L (pt)
GR (1) GR3017920T3 (pt)
HU (1) HUT63339A (pt)
IE (1) IE70910B1 (pt)
IL (1) IL97629A0 (pt)
MX (1) MX9203522A (pt)
MY (1) MY106163A (pt)
NO (1) NO923749L (pt)
OA (1) OA09674A (pt)
PT (1) PT97108B (pt)
WO (1) WO1991014451A1 (pt)
ZA (1) ZA912138B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998010792A1 (en) * 1996-09-11 1998-03-19 Prendergast Patrick T Immune direction therapy
CN111574621B (zh) * 2020-04-30 2022-03-29 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种中和eb病毒的单克隆抗体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614810A (en) * 1984-09-24 1986-09-30 Pennwalt Corporation 4,5-dihydro-4-oxo-2-[(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof
US5231012A (en) * 1989-06-28 1993-07-27 Schering Corporation Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)

Also Published As

Publication number Publication date
FI924278A0 (fi) 1992-09-24
JP2509774B2 (ja) 1996-06-26
MX9203522A (es) 1992-07-01
ES2076526T3 (es) 1995-11-01
HUT63339A (en) 1993-08-30
IL97629A0 (en) 1992-06-21
DE69112392D1 (de) 1995-09-28
EP0522010A1 (en) 1993-01-13
GR3017920T3 (en) 1996-01-31
FI924278A7 (fi) 1992-09-24
EP0522010B1 (en) 1995-08-23
IE910942A1 (en) 1991-10-09
AU650013B2 (en) 1994-06-09
IE70910B1 (en) 1997-01-15
DK0522010T3 (da) 1996-01-15
KR960004856B1 (ko) 1996-04-16
CA2079230A1 (en) 1991-09-27
JPH05501116A (ja) 1993-03-04
US5756342A (en) 1998-05-26
DE69112392T2 (de) 1996-02-01
NO923749D0 (no) 1992-09-25
MY106163A (en) 1995-03-31
FI924278L (fi) 1992-09-24
ZA912138B (en) 1991-12-24
CA2079230C (en) 2001-02-13
CN1056245A (zh) 1991-11-20
WO1991014451A1 (en) 1991-10-03
ATE126704T1 (de) 1995-09-15
AU7588291A (en) 1991-10-21
PT97108B (pt) 1998-10-30
NO923749L (no) 1992-09-25
OA09674A (en) 1993-05-15

Similar Documents

Publication Publication Date Title
DK156688D0 (da) Praeparat til behandling af virusinfektioner
ES515177A0 (es) Procedimiento para el tratamiento de inmunoglobulina de suero.
PT89573A (pt) Metodo para a reducao de respostas mediadas por imunoglobulina e
MX9203629A (es) Composiciones de anticuerpos monoclonales para el tratamiento profilactico o terapeutico de infecciones bacterianas debidas a estreptococos del grupo b.
GB9009106D0 (en) Processes and intermediates for synthetic antibody derivatives
DE50015629D1 (de) Verwendung cd28 spezifischer monoklonaler antikörpsetzung zur behandlung von virusinfektionen
DK0504307T3 (da) Fremgangsmåde til behandling af septisk shock
PT97108A (pt) Processo para a preparacao de medicamentos contendo antagonistas de bcrf1 uteis para o tratamento de infeccoes pelo virus de epstein-barr
ATE98872T1 (de) Antagonist fuer interleukin-5 zur verhuetung oder verminderung von eosinophilie.
ATE122100T1 (de) Humaner monoklonaler antikörper und diesen enthaltende arzneimittelzusammensetzung zur behandlung von pseudomonasinfektionen.
FI874273L (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
ATE110786T1 (de) Monoklonaler antikörper gegen exotoxin a von pseudomonas aeruginosa.
RO85246A3 (ro) Procedeu de preparare a antigenului citomecanic uman

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910724

FG3A Patent granted, date of granting

Effective date: 19980724

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20020131